University Hospital, Clermont-Ferrand: Parkinson Disease trials
The registry lists 25 Parkinson Disease studies with University Hospital, Clermont-Ferrand as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 1Phase 4 3No phase 19(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Idiopathic Parkinson's Disease: Interest of an Early Group-Based Cognitive Rehabilitation Program (LIFECOG-PD)Not yet recruitingNCT07813156Not applicable
- Primary Parkinsonian Pain: Clinical Association and PhenotypeNot yet recruitingNCT07702266
- Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control SubjectsRecruitingNCT04735172Not applicable
- Evaluation of Impaired Mobility in Chronic Illness Constitution of a CohortRecruitingNCT04375280Not applicable
- Towards the Use of Instrumented Tests for Screening the Risk of Falling in Patients With Chronic Illness.CompletedNCT04368858Not applicable
- Circadian Character of Food Compulsions and Impulses Control Disorders in Parkinsonian Patients With and Without Resting Leg SyndromeCompletedNCT03818243Not applicable
- Role of Retina in Mechanisms of Illusions and Visual Hallucinations Observed in Idiopathic Parkinson's DiseaseStatus unknownNCT03454269Not applicable
- Evolution of RBD in PDStatus unknownNCT03047408Not applicable
- Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label StudyStatus unknownNCT02934919Phase 2
- Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's DiseaseStatus unknownNCT02930512
- Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior DisorderCompletedNCT02824341Not applicable
- One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson's Disease Progression?Status unknownNCT02816645Not applicable
- Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's DiseaseStatus unknownNCT02816619Not applicable
- Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography.Status unknownNCT02796040Not applicable
- Role of Mesocorticolimbic Pathway in Apathy of Patients With Parkinson's Disease. - Study Using Diffusion Tensor Imaging and Fibres TrackingCompletedNCT01794195Not applicable
- Effect of Deep Brain Stimulation on Gait of Patients With Parkinson's Disease Depending on Electrode Location in Subthalamic AreaCompletedNCT01782638Phase 4
- Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian PatientsStatus unknownNCT01780467Phase 4
- Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center StudyStatus unknownNCT01765257Phase 4
- Optimization of fMRI for the Study of Basal Ganglia Activation in Parkinson's DiseaseCompletedNCT01429909Not applicable
- Facial Expression Recognition and Mirror Neurons in Parkinson's DiseaseStatus unknownNCT01315405Not applicable
- Glucose Tolerance in Patients With an Idiopathic Parkinson's DiseaseStatus unknownNCT01114321Not applicable
- Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles)Status unknownNCT00909883Phase 3
- Facial Expression Recognition of Emotion and Categorization of Emotional Words in Parkinson's Disease. Impact of L-Dopa and Deep Brain Stimulation of Subthalamic NucleusCompletedNCT00664157Not applicable
- Impact of Deep Brain Stimulation of Subthalamic Nucleus on the Hepatic Glucose Production in Parkinson's DiseaseTerminatedNCT00663312Not applicable
- Body Weight Gain, Parkinson, Subthalamic StimulationCompletedNCT00529724Phase 2